Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Sun Pharma to acquire Innovcare Lifesciences for $28.7m
  • M&A / Deals

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Pharmaceutical Technology

Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).

Read full story

pharminent June 22, 2026 (Last updated: June 22, 2026)

Pharmaceutical Technology

Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: The first 14 days: How specialty programs set patients up for success
Next: Post-marketing oncology studies: Enabling faster recruitment and lower costs

Related Stories

  • M&A / Deals

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

pharminent July 10, 2026
  • M&A / Deals

GSK ends dementia alliance with Alector after setbacks

pharminent July 9, 2026
  • M&A / Deals

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

pharminent July 8, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.